HTLV-1 and blood donation

Area of Science:

• Virology
• Public Health
• Hematology

Background:

• Human T-cell leukaemia virus type 1 (HTLV-1) is a retrovirus linked to serious conditions like adult T-cell lymphoma and HTLV-associated myelopathy.
• Blood donation screening is a critical component of public health surveillance for infectious diseases.

Purpose of the Study:

• To analyze current Human T-cell leukaemia virus type 1 (HTLV-1) testing practices in blood banks.
• To evaluate the contribution of blood donation screening to the public health surveillance of HTLV-1.
• To highlight missed opportunities in HTLV-1 screening within blood banking.

Main Methods:

• Utilized data from a recent World Health Organization (WHO) report.
• Examined existing protocols for HTLV-1 testing in blood collection facilities.
• Assessed the impact of current screening on national and global HTLV-1 surveillance.

Main Results:

• Current blood bank testing for HTLV-1 is often insufficient, leading to missed opportunities for detection.
• Existing screening practices do not fully leverage the potential of blood donations for public health surveillance.
• Significant gaps exist in the systematic identification and reporting of HTLV-1 cases through blood banks.

Conclusions:

• There is a need to enhance HTLV-1 screening protocols in blood banks.
• Improved screening can significantly bolster public health surveillance efforts for HTLV-1.
• Optimizing blood donation testing is crucial for controlling the spread and impact of HTLV-1.